Ms Johane Boucher-Champagne, SFBC Anapharm’s Chief Operating Officer, is happy to announce the nomination of Ms Isabel Desmarais as Assistant Chief Operating Officer.
QUEBEC, May 6, 2005 -- Ms Johane Boucher-Champagne, SFBC Anapharm's Chief Operating Officer, is happy to announce the nomination of Ms Isabel Desmarais as Assistant Chief Operating Officer. Graduated in Pharmacy at the Universit Laval in 1995, Ms Desmarais also holds a Master in Hospital Pharmacy and a MBA in Business Management, completed in 2003 while working at SFBC Anapharm.
"Her expertise, her professionalism and her large contribution to SFBC Anapharm's business makes her the ideal candidate for this newly created job within our general management team. The dazzling expansion of our organization during the last years and the numerous challenges we have to face require excellence. I am therefore very happy to rely on such a quality person to help us in taking them up", declared Ms Boucher-Champagne
Since she joined SFBC Anapharm in 1998, Isabel Desmarais quickly got promotions within the company, being first a protocol writer, then a project manager and assistant director in our Scientific and Regulatory Affairs division. Having a strong 10-year experience in the pharmaceutical field, Isabel Desmarais has been acting as Project Management Director for 3 years at SFBC Anapharm, where she greatly contributed to the elaboration and development of many efficient and fast management programs and procedures for all critical aspects of studies and this, while respecting the highest quality standards.
Founded in Quebec in 1994, Anapharm, member of SFBC International, is the most important private contract research organisation specialized in phases I & II and bioequivalence tests in North America. The company offers leading services to pharmaceutical and biopharmaceutical companies all over the world. The company employs more than 700 specialists located in four sites in Quebec, its head office, in Montreal, Trois-Rivires and Toronto.
Driving Diversity with the Integrated Research Model
October 16th 2024Ashley Moultrie, CCRP, senior director, DEI & community engagement, Javara discusses current trends and challenges with achieving greater diversity in clinical trials, how integrated research organizations are bringing care directly to patients, and more.
AI in Clinical Trials: A Long, But Promising Road Ahead
May 29th 2024Stephen Pyke, chief clinical data and digital officer, Parexel, discusses how AI can be used in clinical trials to streamline operational processes, the importance of collaboration and data sharing in advancing the use of technology, and more.
The Rise of Predictive Engagement Tools in Clinical Trials
November 22nd 2024Patient attrition can be a significant barrier to the success of a randomized controlled trial (RCT). Today, with the help of AI-powered predictive engagement tools, clinical study managers are finding ways to proactively reduce attrition rates in RCTs, and increase the effectiveness of their trial. In this guide, we look at the role AI-powered patient engagement tools play in clinical research, from the problems they’re being used to solve to the areas and indications in which they’re being deployed.